REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
Clinical trial NCT00287287 · COMPLETED
Trial details
- NCT number
- NCT00287287
- Sponsor
- Kenneth Ain
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2010-07-06
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.